drugset / Trial / NCT01248650
Safety Study of TRK-820 for Patient With Hemodialysis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to observe pharmacokinetics and safety of nalfurafine hydrochloride in patients receiving hemodialysis.
Timeline
- Start
- 2008-12
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nalfurafine | Small molecule | 2.5 ug | Oral |
| Comparator | Nalfurafine | Small molecule | 5 ug | Oral |